The National Health Service immunisation schedule includes vaccines which protect against the capsular groups of meningococcal infection A, B, C, W, and Y in the form of four vaccines: Meningococcal capsular group C (MenC), Haemophilus influenzae type b/meningococcal capsular group C (Hib/MenC), Meningococcal capsular groups A, C, W and Y (Men ACWY) and Meningococcal capsular group B (MenB).
The MenB immunisation for infants was introduced on 1 September 2015. Preliminary vaccine coverage for children born in July 2015 was 94.0% for one dose and 84.8% for two doses when measured at six months of age.
MenACWY immunisation was added to the national immunisation programme in August 2015 following advice from the Joint Committee on Vaccination and Immunisation (JCVI) to respond to the rising number of meningococcal W cases. The objective of the programme is to immunise all teenagers in school years 9 to 13 before they complete academic year 13. This is being done by replacing the routine adolescent MenC booster given in years 9 or 10 with the MenACWY vaccine, and by a series of catch-up campaigns targeting older teenagers. Data for the MenACWY vaccine is not yet publicly available.
The Department is advised on all immunisation matters, by the JCVI, an independent expert advisory committee.